2,3-dimethylmaleic anhydride has been researched along with Body Weight in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, H; Dai, Y; Gai, S; He, F; Kuang, Y; Li, C; Lin, J; Liu, B; Lv, R; Xing, B; Xu, J; Yang, D; Yang, P | 1 |
| Hirano, T; Kamada, H; Kaneda, Y; Mayumi, T; Tsunoda, S; Tsutsumi, Y; Yamamoto, Y | 1 |
2 other study(ies) available for 2,3-dimethylmaleic anhydride and Body Weight
| Article | Year |
|---|---|
Charge convertibility and near infrared photon co-enhanced cisplatin chemotherapy based on upconversion nanoplatform.
Topics: Antineoplastic Agents; Body Weight; Cell Survival; Cisplatin; HeLa Cells; Humans; Hydrolysis; Infrared Rays; Luminescence; Maleic Anhydrides; Nanoparticles; Photons; Polyamines; Prodrugs; Spectrophotometry, Ultraviolet; Succinic Anhydrides; Tomography, X-Ray Computed; Tumor Burden | 2017 |
Bioconjugation of tumor necrosis factor-alpha with the copolymer of divinyl ether and maleic anhydride increasing its antitumor potency.
Topics: Animals; Antineoplastic Agents; Body Weight; Chromatography, Gel; Humans; Maleic Anhydrides; Mice; Models, Chemical; Neoplasms, Experimental; Platelet Count; Pyran Copolymer; Tumor Necrosis Factor-alpha | 1997 |